
Aussie-based baby formula at centre of unsettling ‘malnutrition' fears
Coco2 Australia Pty Ltd sells what it has described as the 'world's first coconut-based infant formula — a breakthrough in plant-based nutrition for babies'.
WATCH THE VIDEO ABOVE: Baby formula maker admits error in scoop size.
In an email to customers, which has been obtained by 7NEWS, Coco2 admitted an error in its scoop size.
'We're reaching out with an important update regarding the Coco2 Baby Formula batch you purchased,' the company told customers in the message.
'Due to natural variations in bulk density, we discovered that the included scoop holds slightly less powder than usual.'
The company encouraged parents to add 50 per cent more powder to a bottle.
'This adjustment is simply to ensure that your baby receives the proper serving size and all the nutrients they need,' the company said.
'We sincerely apologise for any confusion or inconvenience this may have caused.' Aussie parents say their little boy became sick after using a formula made by Coco2 Australia. Credit: 7NEWS Coco2 has admitted there was an error in its scoop size. Credit: 7NEWS
An Australian family who have chosen to remain anonymous claim their baby boy started to become ill after being on the formula for a few weeks.
'He wasn't reaching any of his seven-month milestones, he wasn't sitting up,' the father told 7NEWS.
'He'd look sick, he'd get up, he'd drink, he'd go to sleep and then wake up again in half an hour because he's hungry and we'd feed him again.
'By February he just started to go downhill, just quite lethargic, lost all his colour, lost weight.
'His lips started to crack. He was rashing all around his nose and eyes and so we just went to the GP and he suggested some blood tests.'
The family say they eventually hit the panic button and rushed him to Melbourne's Royal Children's Hospital.
'We had the results saying it doesn't look like it's a blood cancer, but there's something going on, but we don't know what it is,' the dad said.
The family told doctors about the feeding and after being put on a different formula, they say the baby boy began to improve almost immediately.
'Our kid's fine now, he's OK. We don't think there's any long-term issues,' the father said. Tins of the formula now have a sticker covering old feeding guide measurements. Credit: 7NEWS
An official report from doctors at The Royal Children's which 7NEWS has obtained suggests the baby's illness was likely caused by the Coco2 Baby Formula.
'The Coco formula they were previously consuming had made an error in their scoop size and was not delivering adequate nutrition per feed — this is the likely cause for their significant weight loss and malnutrition,' according to the report.
In a statement to 7NEWS the company denied the formula caused the boy's malnutrition, insisting the formula remains safe.
'Following the discovery of a discrepancy in scoop weight, we conducted immediate remeasurement of the formula's density across all production batches to ensure the corrected scoop size accurately reflects the intended serving,' the company said.
'The formula, when prepared using the updated instructions, is fully compliant and safe.
'We must stress that there have been no medically confirmed reports of babies becoming seriously ill due to Coco2 formula.
'Coco2 was developed by infant nutrition specialists and remains unchanged and safe when used as directed. We are deeply committed to maintaining the highest standards of transparency, quality, and care.'
It added that a recall was not necessary because the issue was related to dosage rather than the actual product.
Tins of the formula now have a sticker covering old feeding guide measurements.
Have you experienced something similar? Email: 7ndtips@seven.com.au

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


7NEWS
11 hours ago
- 7NEWS
Robotic surgery at St Vincent's Hospital saves Melbourne man's voice and ability to eat
Melbourne man has had his voice and his life saved by cutting-edge robotic surgery, performed in a world-first procedure at St Vincent's Hospital. Jordan Robotis works in before-and-after-school care and said it all started around Christmas time. 'I sort of was noticing my voice was kind of changing,' he said. 'And then further down, my cousins noticed that there was a lump in my throat. So then I got that checked out from the doctors.' Initially, he said: 'They were a little bit unsure about it,' and after ultrasounds, CT scans and a biopsy, he ended up at St Vincent's Hospital. 'They were able to give me a better understanding of what it actually was,' Robotis said. 'They also put a camera in my nose and into my throat and I was able to actually see the tumour, which was pretty confronting.' The tumour was in a highly complex part of the throat, located between the voice box, tongue and side wall of the throat where critical nerves and arteries are tightly packed. 'I was a little bit, I guess, in shock,' Robotis said. 'Sort of unsure on what it is because obviously you hear about it, you see it everywhere. But when it's you, it's a little bit confronting.' 'You sort of go into survival mode... What do we do now?' After being told at another hospital he might never speak or eat again, Robotis was referred to St Vincent's Professor Ben Dixon, Director of the ENT Head and Neck Service. 'They actually did tell me that I'd lose my voice completely. I would never speak again. I'd never eat again. I would have a feeding tube, all that fun stuff,' Robotis said. 'They said they would do their best to avoid all of those, I guess, critical parts and from what I heard, they were one of the best at what they do.' Professor Dixon told 7NEWS the surgery required 'complete removal with a margin around it,' but the challenge was to preserve critical functions such as breathing, swallowing, speech and voice. 'With a more standard or larger approach… it may have left him with more swallowing dysfunction, voice dysfunction, even potentially requiring a permanent breathing tube,' he said. The team used the da Vinci robot to operate from the inside of the throat outward. 'We were able to go in through the mouth, define the limits of exactly where the tumour was, make precise cuts around the lining of the throat and the voice box so that we could maintain function in as much of it as possible,' Professor Dixon explained. 'Then we were able to go externally through the neck and remove it knowing that we'd made the internal cuts in all the right areas.' 'You need to get it all out in the one go… If you leave bits behind or have positive margins, that could be a disaster.' Jordan had no idea the surgery would be done by a robot. 'I was a little bit unsure at the beginning because obviously you don't really expect to be hearing something like that,' he said. 'But I had full trust and faith in the medical team, so I didn't really stress too much. I knew I was in good hands.' After the tumour was removed, plastic surgeon Dr Edwin Morrison used the Simani microsurgical robot to help reconstruct the area using tissue from Jordan's thigh. 'It's one of a kind. There is no alternative to it,' Dr Morrison said. 'It provides us with unparalleled abilities to operate at the microscopic level. Some would say superhuman. It's probably not that unreasonable to put it that way.' He explained the tissue transfer involved repairing blood vessels just 1mm to 1.5mm in diameter. 'We're restoring a circulation or bringing it back to life, if you will,' he said. 'The confidence in repairing vessels… less than one to one and a half millimetres, is not there (without robotics).' Dr Morrison said their goal was simple. 'At the end of the day, we reconstruct defects, we restore form and function - but what it's really all about is restoring patients… and in Jordan's case, their quality of life after their treatment,' he said. The operation took place on May 5th. Recovery was not easy. 'Coming out of surgery, I was in all sorts. It was a lot. It was probably the hardest few weeks of my life,' Robotis said. 'But after getting out of the first few weeks and coming home, it was a lot easier to kind of start healing.' He's now focused on getting his strength back. Returning to the operating theatre where he underwent his surgery 7NEWS was there as Jordan thanked his doctors for saving his voice and his life. 'I guess… thank you. Just for everything they've done. Just how efficiently and quickly it all kind of happened,' he said. 'That's all I can really appreciate is that I'm here.' Professor Dixon said the case highlights how robotic-assisted surgery is transforming outcomes for patients. 'Jordan being a young man with a tumour in a difficult spot… it's a great example of how using technology in the right case can really allow someone to live with a very high quality of life,' he said. 'And really importantly, offer this to as many people in the public as possible.' And if you're still unsure about robots in the operating room? 'The surgeon still controls the robot,' Professor Dixon explained. 'It is not an automated robot. It's fully controlled by a surgeon.'


The Advertiser
20 hours ago
- The Advertiser
Female-founded AI tool aims to transform women's health
Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research." Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research." Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research." Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research."


West Australian
a day ago
- West Australian
Female-founded AI tool aims to transform women's health
Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research."